Abstract:Drug repositioning, an important method of drug development, is utilized to discover investigational drugs beyond the originally approved indications, expand the application scope of drugs, and reduce the cost of drug development. With the emergence of increasingly drug-disease-related biological networks, the challenge still remains to effectively fuse biological entity data and accurately achieve drug-disease repositioning. This paper proposes a new drug repositioning method named EMPHCN based on enhanced message passing and hypergraph convolutional networks (HGCN). It firstly constructs the homogeneous multi-view information with multiple drug similarity features and then extracts the intra-domain embedding of drugs through the combination of HGCN and channel attention mechanism. Secondly, inter-domain information of known drug-disease associations is extracted by graph convolutional networks combining node and edge embedding (NEEGCN), and a heterogeneous network composed of drugs, proteins and diseases is built as an important auxiliary to enhance the inter-domain message passing of drugs and diseases. Besides, the intra-domain embedding of diseases is also extracted through HGCN. Ultimately, intra-domain and inter-domain embeddings of drugs and diseases are integrated as the final embedding for calculating the drug-disease correlation matrix. Through 10-fold cross-validation on some benchmark datasets, we find that the AUPR of EMPHCN reaches 0.593 (T1) and 0.526 (T2), respectively, and the AUC achieves 0.887 (T1) and 0.961 (T2) respectively, which shows that EMPHCN has an advantage over other state-of-the-art prediction methods. Concerning the new disease association prediction, the AUC of EMPHCN through the five-fold cross-validation reaches 0.806 (T1) and 0.845 (T2), which are 4.3% (T1) and 4.0% (T2) higher than the second best existing methods, respectively. In the case study, EMPHCN also achieves satisfactory results in real drug repositioning for breast carcinoma and Parkinson's disease.

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Drug repositioning based on the heterogeneous information fusion graph convolutional network

A Multimodal Framework for Improving in Silico Drug Repositioning with the Prior Knowledge from Knowledge Graphs

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Drug repositioning with adaptive graph convolutional networks

KG-Predict: A knowledge graph computational framework for drug repurposing

Enhancing Drug Repositioning through Local Interactive Learning with Bilinear Attention Networks

Drug repositioning based on weighted local information augmented graph neural network

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

HeteroKGRep: Heterogeneous Knowledge Graph based Drug Repositioning

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

EKGDR: An End-to-End Knowledge Graph-Based Method for Computational Drug Repurposing

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

DRGCL: Drug Repositioning Via Semantic-enriched Graph Contrastive Learning.

Drug Repositioning Via Multi-view Representation Learning with Heterogeneous Graph Neural Network

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

A Fused Deep Learning Approach to Transform Novel Drug Repositioning